204 related articles for article (PubMed ID: 9794741)
1. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
[TBL] [Abstract][Full Text] [Related]
2. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
3. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.
Suzukawa M; Abbey M; Howe PR; Nestel PJ
J Lipid Res; 1995 Mar; 36(3):473-84. PubMed ID: 7775859
[TBL] [Abstract][Full Text] [Related]
4. Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation.
Jialal I; Grundy SM
Circulation; 1993 Dec; 88(6):2780-6. PubMed ID: 8252691
[TBL] [Abstract][Full Text] [Related]
5. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
Beaudeux JL; Guillausseau PJ; Peynet J; Flourie F; Assayag M; Tielmans D; Warnet A; Rousselet F
Clin Chim Acta; 1995 Aug; 239(2):131-41. PubMed ID: 8542651
[TBL] [Abstract][Full Text] [Related]
6. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
[TBL] [Abstract][Full Text] [Related]
7. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein composition and oxidability in atherosclerotic cardiovascular disease.
Schreier LE; Sanguinetti S; Mosso H; Lopez GI; Siri L; Wikinski RL
Clin Biochem; 1996 Oct; 29(5):479-87. PubMed ID: 8884071
[TBL] [Abstract][Full Text] [Related]
10. Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidation.
Viens L; Athias A; Lizard G; Simard G; Gueldry S; Braschi S; Gambert P; Lallemant C; Lagrost L
J Lipid Res; 1996 Oct; 37(10):2179-92. PubMed ID: 8906595
[TBL] [Abstract][Full Text] [Related]
11. Effect of fish oil on LDL oxidation and plasma homocysteine concentrations in health.
Piolot A; Blache D; Boulet L; Fortin LJ; Dubreuil D; Marcoux C; Davignon J; Lussier-Cacan S
J Lab Clin Med; 2003 Jan; 141(1):41-9. PubMed ID: 12518167
[TBL] [Abstract][Full Text] [Related]
12. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
13. Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well-controlled type 2 diabetes.
Scheffer PG; Bakker SJ; Popp-Snijders C; Heine RJ; Schutgens RB; Teerlink T
Diabetes Metab Res Rev; 2001; 17(6):459-66. PubMed ID: 11757082
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
[TBL] [Abstract][Full Text] [Related]
15. Normal prostaglandinuria E2 in Gitelman's syndrome, the hypocalciuric variant of Bartter's syndrome.
Lüthy C; Bettinelli A; Iselin S; Metta MG; Basilico E; Oetliker OH; Bianchetti MG
Am J Kidney Dis; 1995 Jun; 25(6):824-8. PubMed ID: 7771477
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia.
Blom HJ; Kleinveld HA; Boers GH; Demacker PN; Hak-Lemmers HL; Te Poele-Pothoff MT; Trijbels JM
Eur J Clin Invest; 1995 Mar; 25(3):149-54. PubMed ID: 7781660
[TBL] [Abstract][Full Text] [Related]
17. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content.
Tribble DL; van den Berg JJ; Motchnik PA; Ames BN; Lewis DM; Chait A; Krauss RM
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):1183-7. PubMed ID: 8302851
[TBL] [Abstract][Full Text] [Related]
18. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.
Fuller CJ; Grundy SM; Norkus EP; Jialal I
Atherosclerosis; 1996 Jan; 119(2):139-50. PubMed ID: 8808491
[TBL] [Abstract][Full Text] [Related]
19. Effect of n-3 fatty acid-rich fish oil supplementation on the oxidation of low density lipoproteins.
Frankel EN; Parks EJ; Xu R; Schneeman BO; Davis PA; German JB
Lipids; 1994 Apr; 29(4):233-6. PubMed ID: 8177016
[TBL] [Abstract][Full Text] [Related]
20. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein.
Geetha A; Surendran R
Pharmazie; 2005 Aug; 60(8):609-13. PubMed ID: 16124405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
